Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its first quarter 2014 financial results conference call for 8:30 a.m. ET on Thursday, May 1, 2014. The schedules for the press release and conference call are as follows:
• | Q1 2014 Press Release: | May 1, 2014 at 7:00 a.m. ET | ||||||||||||
• | Q1 2014 Conference Call: | May 1, 2014 at 8:30 a.m. ET | ||||||||||||
• | Domestic Dial-In Number: | 877-407-8037 | ||||||||||||
• | International Dial-In Number: | 201-689-8037 | ||||||||||||
• | Conference ID # | 13580001 | ||||||||||||
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13580001.
The conference call will also be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at www.incyte.com.
Contacts:
Pamela M. Murphy
Vice
President, Investor Relations & Corporate Communications
302-498-6944
